Stimulant medication to treat attention-deficit/hyperactivity disorder

Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort

“…Additionally, most women treated with ADHD medication during pregnancy used only one class of ADHD medication, predominantly the stimulant class, which aligns with other studies reporting stimulants to be the most prescribed medications for ADHD due to a higher pharmacological response than that of non‐stimulants 40 . Furthermore, we report that methylphenidate was the most widely used ADHD medication among our women, which was observed in several studies in non‐pregnant women 41‐43 . This result is also in line with the current Canadian guidelines for ADHD treatment.…”

“…40 Furthermore, we report that methylphenidate was the most widely used ADHD medication among our women, which was observed in several studies in non-pregnant women. [41][42][43] This result is also in line with the current Canadian guidelines for ADHD treatment. Specifically, stimulants, including methylphenidate, are recommended as the first-line pharmacological treatment, whereas non-stimulants such as atomoxetine should be considered as second-line treatments.…”